11 results on '"Le Tourneau C"'
Search Results
2. Inequality factors in access to early-phase clinical trials in oncology in France: results of the EGALICAN-2 study
3. Two phase I studies of BI 836880, a vascular endothelial growth factor/angiopoietin-2 inhibitor, administered once every 3 weeks or once weekly in patients with advanced solid tumors
4. Access to early-phase clinical trials in older patients with cancer in France: the EGALICAN-2 study
5. Impact of the timing of tumor assessments on median progression-free survival in clinical trials in advanced cancer patients
6. Assessing the impact of organ-specific lesion dynamics on survival in patients with recurrent urothelial carcinoma treated with atezolizumab or chemotherapy
7. Prognostic value of tumor mutational burden in patients with oral cavity squamous cell carcinoma treated with upfront surgery
8. Combining immunotherapy with an epidrug in squamous cell carcinomas of different locations: rationale and design of the PEVO basket trial
9. Intrapatient comparisons of efficacy in a single-arm trial of entrectinib in tumour-agnostic indications
10. Relevance of a molecular tumour board (MTB) for patients' enrolment in clinical trials: experience of the Institut Curie.
11. Patient-reported tolerability of adverse events in phase 1 trials.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.